Related Experiment Video
Updated: Aug 3, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
New uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disorders
Fatima Jamshed1,2, Farzaneh Dashti1, Xinshou Ouyang1
1Section of Digestive Diseases, Yale School of Medicine, New Haven, CT 06510, United States.
Abstract:
Repurposing of the widely available and relatively cheap generic cardiac gly-coside digoxin for non-cardiac indications could have a wide-ranging impact on the global burden of several diseases. Over the past several years, there have been significant advances in the study of digoxin pharmacology and its potential non-cardiac clinical applications, including anti-inflammatory, antineoplastic, metabolic, and antimicrobial use. Digoxin holds promise in the treatment of gastrointestinal disease, including nonalcoholic steatohepatitis and alcohol-associated steatohepatitis as well as in obesity, cancer, and treatment of viral infections, among other conditions. In this review, we provide a summary of the clinical uses of digoxin to date and discuss recent research on its emerging applications.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Cardiomyopathy II: Dilated Cardiomyopathy
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Heart Failure VI: Adjunct Therapies

